| Item Type | Name |
|
Concept
|
Antidepressive Agents
|
|
Concept
|
Antibodies, Viral
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Anticoagulants
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Carbon Dioxide
|
|
Concept
|
Antihypertensive Agents
|
|
Concept
|
Codeine
|
|
Concept
|
Aspirin
|
|
Concept
|
Cholecalciferol
|
|
Concept
|
Calcitriol
|
|
Concept
|
Blood Glucose
|
|
Concept
|
Nonprescription Drugs
|
|
Concept
|
Barium
|
|
Concept
|
Biological Products
|
|
Concept
|
Calcifediol
|
|
Concept
|
Endoribonucleases
|
|
Concept
|
Cannabidiol
|
|
Concept
|
Creatinine
|
|
Concept
|
Hemoglobins
|
|
Concept
|
Contraceptives, Oral
|
|
Concept
|
Drug Industry
|
|
Concept
|
Insulin
|
|
Concept
|
Drug Therapy
|
|
Concept
|
Drug Evaluation, Preclinical
|
|
Concept
|
Interferons
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Drug Information Services
|
|
Concept
|
Drug Labeling
|
|
Concept
|
Hydralazine
|
|
Concept
|
Hypoglycemic Agents
|
|
Concept
|
Safety
|
|
Concept
|
Oxycodone
|
|
Concept
|
Drug Prescriptions
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Pyrrolidines
|
|
Concept
|
Ticlopidine
|
|
Concept
|
United States Food and Drug Administration
|
|
Concept
|
Succinylcholine
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Warfarin
|
|
Concept
|
Cholesterol, LDL
|
|
Concept
|
Vitamins
|
|
Concept
|
Drug Costs
|
|
Concept
|
Drug Approval
|
|
Concept
|
Drugs, Generic
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Safety Management
|
|
Concept
|
Cyclooxygenase 2 Inhibitors
|
|
Concept
|
Drug Resistance, Bacterial
|
|
Concept
|
Drug Utilization Review
|
|
Concept
|
Pyrimidinones
|
|
Concept
|
Anti-Retroviral Agents
|
|
Concept
|
Antipsychotic Agents
|
|
Concept
|
Prescription Drugs
|
|
Concept
|
Vitamin D
|
|
Concept
|
Respiratory System Agents
|
|
Concept
|
Anti-HIV Agents
|
|
Concept
|
Drug Discovery
|
|
Concept
|
Antibodies, Neutralizing
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Cardiovascular Agents
|
|
Concept
|
Drug Administration Schedule
|
|
Concept
|
Omeprazole
|
|
Concept
|
Platelet Aggregation Inhibitors
|
|
Concept
|
Tramadol
|
|
Concept
|
Proton Pump Inhibitors
|
|
Concept
|
Drug Recalls
|
|
Concept
|
Patient Safety
|
|
Academic Article
|
Perspective and the measurement of costs and benefits for cost-effectiveness analysis in schizophrenia.
|
|
Academic Article
|
Continuity of antibiotic therapy in patients admitted from the emergency department.
|
|
Academic Article
|
Consumers' perceptions about risk of and access to nonprescription medications.
|
|
Academic Article
|
Communication failures in patient sign-out and suggestions for improvement: a critical incident analysis.
|
|
Academic Article
|
Risks and benefits of risk-management plans.
|
|
Academic Article
|
Prioritizing future research on off-label prescribing: results of a quantitative evaluation.
|
|
Academic Article
|
The Coase Theorem and patient safety.
|
|
Academic Article
|
Importance of distinguishing supported and unsupported off-label drug use.
|
|
Academic Article
|
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.
|
|
Academic Article
|
Medication discrepancies in resident sign-outs and their potential to harm.
|
|
Academic Article
|
Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-centre study.
|
|
Academic Article
|
Private manufacturers' thresholds to invest in comparative effectiveness trials.
|
|
Academic Article
|
Improving inpatients' identification of their doctors: use of FACE cards.
|
|
Academic Article
|
Nonprofit biomedical companies.
|
|
Academic Article
|
Strategies for effective on-call supervision for internal medicine residents: the superb/safety model.
|
|
Academic Article
|
How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatments.
|
|
Academic Article
|
Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes.
|
|
Academic Article
|
Economic analysis in patient safety: a neglected necessity.
|
|
Academic Article
|
Cost-effectiveness analysis in oncology.
|
|
Academic Article
|
What's in a name generator? Choosing the right name generators for social network surveys in healthcare quality and safety research.
|
|
Academic Article
|
How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agenda.
|
|
Academic Article
|
How much diagnostic safety can we afford, and how should we decide? A health economics perspective.
|
|
Academic Article
|
Clinical impact of treatment timing for chronic hepatitis C infection: a decision model.
|
|
Academic Article
|
Financial Burden and Impoverishment Due to Cardiovascular Medications in Low and Middle Income Countries: An Illustration from India.
|
|
Academic Article
|
A Missed Opportunity to Improve Patient Satisfaction? Patient Perceptions of Inpatient Communication With Their Primary Care Physician.
|
|
Academic Article
|
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
|
|
Academic Article
|
Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.
|
|
Academic Article
|
Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing.
|
|
Academic Article
|
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
|
|
Academic Article
|
Development and testing of a web module to IMPROVE generic prescribing of oral contraceptives among primary care physicians.
|
|
Academic Article
|
Development and testing of a module to promote generic oral contraceptive prescribing among nurse practitioners.
|
|
Academic Article
|
Physician and Nurse Practitioner Attitudes on Generic Prescribing of Oral Contraceptive Pills and Antidepressants.
|
|
Academic Article
|
Prevalence and Persistence of Cost-Related Medication Nonadherence Among Medicare Beneficiaries at High Risk of Hospitalization.
|
|
Academic Article
|
The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System.
|
|
Academic Article
|
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses.
|
|
Academic Article
|
Improving natural product research translation: From source to clinical trial.
|
|
Academic Article
|
Decreasing rates of cost-related medication non-adherence by age advancement among American generational cohorts 2004-2014: a longitudinal study.
|
|
Concept
|
Drug-Related Side Effects and Adverse Reactions
|
|
Concept
|
Vitamin K Epoxide Reductases
|
|
Concept
|
Cytochrome P-450 CYP2C19
|
|
Grant
|
Hospital Medicine and Economics Centers for Education &Research for Therapeutics
|
|
Grant
|
19th Annual Health Economics Conference
|
|
Academic Article
|
Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021.
|
|
Academic Article
|
Industry Payments for Vibegron and Prescribing Patterns Among Urologic Clinicians.
|